MDM2 and ovarian cancer: We have also demonstrated that the Ras/ER/MDM2 pathway is critical for NIH3T3 cell transformation (11,12) and that blockage of this pathway by inhibitors or MDM2 siRNA induces p53 and p21 expression and suppresses cell proliferation in estrogen-dependent cancer such as endometrial and ovarian cancer (13).